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Abstract 
Scoping studies have demonstrated that ceragenins, when linked to water-treatment membranes 
have the potential to create biofouling resistant water-treatment membranes.  Ceragenins are 
synthetically produced molecules that mimic antimicrobial peptides. Evidence includes 
measurements of CSA-13 prohibiting the growth of and killing planktonic Pseudomonas 
fluorescens.  In addition, imaging of biofilms that were in contact of a ceragenin showed more 
dead cells relative to live cells than in a biofilm that had not been treated with a ceragenin.  This 
work has demonstrated that ceragenins can be attached to polyamide reverse osmosis (RO) 
membranes, though work needs to improve the uniformity of the attachment.  Finally, methods 
have been developed to use hyperspectral imaging with multivariate curve resolution to view 
ceragenins attached to the RO membrane.  Future work will be conducted to better attach the 
ceragenin to the RO membranes and more completely test the biocidal effectiveness of the 
ceragenins on the membranes. 
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1 INTRODUCTION 
Biofouling impacts membrane separation processes for many industrial applications such as 
desalination[Watson et al., 2003], waste-water treatment [Ridgway et al., 1983], oil and gas 
extraction, and power generation.  For example, in one desalination pilot plant using 
nanofilturation membranes, the normalized pressure drop (actual pressure drop normalized for 
flow and temperature) increased from about 200 to 400 kPa within a two-week period 
[Vrouwenvelder et al., 1998].  Biological analysis of the membranes show high biofilm densities 
on the feed side of the spiral wound membrane elements.  Ridgway et al. [1983] give evidence of 
microbial fouling in Water Factory 21, a waste-water treatment facility in Southern California.  
Biofouling results in a loss of permeate flux and increase in energy use.  Biofouling becomes an 
issue in the energy sector as water recycling becomes more and more prevalent.  Examples 
include re-use of cooling water and water used for steam injection for heavy oil extraction.  
Other sectors that need ultrapure water, such as pharmaceuticals and the microchips and 
electronics industries, can also benefit from biofouling resistant membranes. 
We present preliminary investigations on the ability of ceragenins to create biofouling resistant 
water-treatment membranes.  Ceragenins are synthetically produced molecules that mimic 
antimicrobial peptides [Savage, 2002].  Humans have an innate immune system comprised of, in 
part, antimicrobial peptides capable of the detection, prevention and fighting of bacterial 
infections.  The characteristics of these peptides is that there is little likelihood that they will 
develop resistance, they are capable of rapidly killing target organisms, they have a broad 
spectrum of activity and they are selectively toxic to prokaryotic cells over eukaryotic cells (e.g., 
bacteria over human cells).  However, despite these promising attributes, there are considerable 
challenges in the clinical application of candidate peptide therapies [Jenssen et al., 2006].  
Paul Savage invented the synthetic molecule that mimics the antimicrobial peptides, ceragenins 
[Savage et al., 2002]. They also display broad-spectrum bactericidal activity against Gram-
positive and -negative organisms, including drug resistant bacteria.  They are simple to prepare 
and purify on a large scale and are amenable to broad usage because it is anticipated that they 
will not engender resistance.  They have been incorporated into catheter segments to prevent 
adherence of organisms.  Polymeric forms of ceragenins have also been incorporated into 
medical devices for sustained release to prevent infection. 
Use of ceragenins on water-treatment membranes has not been investigated.  Creation of 
biofouling resistant membranes will assist in creation of clean water and energy with lower 
energy usage.  Ceragenins are synthetically produced antimicrobial peptide mimics that display 
broad-spectrum bactericidal activity.  Use of ceragenins on water-treatment membranes is novel. 
This report is organized into four sections.  Section 1, this section, is the introduction.  The 
synthesis of the ceragenins used in this work as well as the methods for attaching the ceragenins 
to water-treatment membranes are presented in Section 2.  Testing of the biocidal activity of the 
ceragenins are discussed in Section 3.  Finally, Section 4, summarizes the work and discusses 
future work. 
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2 CERAGENIN SYNTHESIS AND ATTACHMENT 
This section discusses the synthesis of the ceragenins created for this study, CSA-105 and CSA-
108.  In addition the attachment methods for these ceragenins are included.  Finally, a 
presentation of the imaging of the ceragenins, both alone and attached to the membranes is 
presented. 
2.1 Synthesis of Ceragenins 
2.1.1 Background 
Paul Savage and his research group have prepared over 100 different ceragenin analogs.  The 
structure of a typical ceragenin, CSA-13, and the starting material, cholic acid, are shown in 
Figure 1.  Ceragenins are based on a steroid core (the system of four fused saturated rings) with 
several substituents arranged in such a way that one face of the molecule is hydrophilic while the 
other face is hydrophobic.  In the case of CSA-13, it is the three primary amines (which become 
ammonium salts when protonated) that cause the near face of the molecule to be hydrophilic.  It 
is this arrangement of hydrophilic and hydrophobic regions that enables ceragenins to mimic 
antimicrobial peptides.  The substituent on the upper right corner of a ceragenin (when drawn as 
CSA-13 is arranged in Figure 1) can be varied without having a large impact on the biocidal 
activity of the ceragenin.  So that region of the molecule will be used as a “handle” for attaching 
the specific functionalities desired for this project. 
2.1.2 Synthesis   
This project requires the addition of two new features to the ceragenin core.  First, a reactive 
group is needed to serve as the point of attachment to a tether which will covalently connect the 
ceragenin to the membrane surface.  Second, an attached fluorophore is needed in order to “see” 
the ceragenin in order to verify that it has been attached to the membrane and to quantify the 
density of ceragenins present.  The Savage group prepared two new ceregenins bearing these 
features for this project.  A connector consisting of two amide groups was used to attach both the 
reactive attachment group (an allyl group) and the fluorophore, this connector will be referred to 
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cholic acid                                                                    CSA-13
Figure 1:  A typical ceragenin, CSA-13, and its precursor, cholic acid. 
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as the “amide connector” for remaining portion of this document.  The synthetic schemes are 
shown in Figures 2 and 3. 
In CSA-105, the point of attachment is the terminal alkene and in CSA-108, the point of 
attachment is the N-hydroxysuccinimide ester.  After the attachment procedure, the Fmoc groups 
on the amines on CSA-108 will be removed in a deprotection step with an organic base.  In both 
CSA-105 and CSA-108, the fluorophore is NBD, the heteroatom-containing fused ring system 
on the right side of both ceregenins as shown in Figures 2 and 3.  CSA-109 is the same as CSA-
105 without the NBD fluorophore. 
2.2 Attachment of Ceragenins 
2.2.1 Attachment Procedure 
Two different attachment methods were planned for the newly-prepared ceragenins.  Method 1 is 
based on the report of Belfer et al. [1998] in which acrylate-type oligomers were attached to the 
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Figure 2. Synthetic scheme for CSA-105. 
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Osurface of reverse osmosis (RO) membranes by a radical reaction in which the membrane was 
immersed in a solution of monomers and initiating agent.  The RO membranes used were GE 
SetaTM brackishwater desalination polyamide membranes purchased from GEOsmonics (part 
number 1221916 or 1206368).  In that report it is unclear what the point of attachment on the 
membrane surface is since the surface is a crosslinked poly(amide).  However the attachment of 
poly(acrylate)-type oligomers was verified after extensive washing with water.  In method 1 
(Figure 4), a mixture of CSA-105 and acrylic acid in water was placed on the surfaces of six RO 
membranes, each bounded by a PTFE o-ring.  A solution of initiator was added to each and the 
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Figure 3. Synthetic scheme for CSA-108. 
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o-rings were then covered to limit evaporation.  The reactions were allowed to take place at room 
temperature and pairs of samples were removed and rinsed thoroughly with water after time 
intervals of 1, 2, and 24 hours.  This method has the advantage that each of the oligomers formed 
should contain multiple ceragenins, so even if the number of attached oligomers is low, the 
density of ceragenins could be high. 
Method 2 is based on previous work by the Savage group [Ding et al., 2004] in which a 
ceregenin with a primary amine reacted with an activated ester to form an amide linkage with the 
ceragenin.  For method 2 (Figure 5), the ceragenin (CSA-108) has an activated ester (an N-
hydroxysuccinimide group) will readily react with a free amine on the surface of the RO 
membrane to form an amide linkage.  This method is the simplest, most direct way of attaching 
ceragenins to membranes but it will only allow for one ceragenin to attach per free amine on the 
surface.  Since the concentration of free amines on RO membranes is not well determined, it 
remains to be seen if this method will impart enough biocidal character to the membranes to 
CSA-105
RO membrane
HO
O
+
COOHCOOHCOOHCOOHCOOHCOOH
+ initiator
CSA-105 CSA-105
Figure 4.  Attachment method 1. 
H2N
RO membrane with 
amines on surface
+ HNO
O
CSA-108
CSA-108
O
N
O
O
Figure 5.  Attachment method 2. 
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deter biofouling.  Additionally, the lack of mobility of the attached ceragenins might reduce their 
efficacy.  If this is determined to be a problem, future experiments will explore the use of 
oligomeric poly(ethylene glycol)-based tethers to attach the ceragenin 
2.2.2 Imaging of Treated Membrane 
2.2.2.1 Background and Methods 
Hyperspectral imaging was used to characterize and quantify the amount of ceragenin attached to 
the RO membranes.  Hyperspectral imaging when combined with Multivariate Curve Resolution 
(MCR) is a powerful imaging technique for attaining quantitative information from fluorescence 
hyperspectral images [Haaland et al., 2007; Martinez et al., 2003; Nieman et al., 2006; 
Sutherland et al., 2007; Timlin et al., 2005].  Overlapping fluorophores are problematic for many 
traditional fluorescence microscopy techniques, however hyperspectral imaging with MCR 
analysis allows us to separate many overlapping fluorophores and create interpretable 
quantitative images for both known and unknown biological samples.  MCR can provide a 
relative quantitative analysis of the hyperspectral image data without the need for standards, and 
it discovers all the emitting species present in an image, even those in which we have no a priori 
information. 
For this project, we employed two hyperspectral imagers designed and built at Sandia National 
Laboratories.  The first imager, the hyperspectral scanner, was originally built to scan and 
quantify multiple fluorophores on DNA microarray slides, however this imager is also useful for 
many applications in which large areas need to be scanned and imaged [Sinclair et al., 2004].   
This hyperspectral scanner was used to image large areas of the RO membranes and quantify the 
amount ceragenin attached to the membrane surface. 
For this study, the hyperspectral scanner was used to evaluate ceragenins attachment.  A 60 mm2 
area of the dry membranes was imaged using a 488 nm excitation laser and the resultant 
fluorescence emission was collected onto an electron multiplying charged-coupled device 
(EMCCD) detector.  An infinity-corrected 10× apochromatic objective was used attaining a final 
pixel size of 30 m × 30 m.  At this resolution, each image consisted of 66,000 pixels with each 
pixel having an emission spectrum composed of 532 wavelengths, from 490 to 890 nm, and a 
spectral resolution of 3 nm.  After the collection of the image data, these data were preprocessed 
to remove cosmic spikes that may have been inadvertently collected onto the EMCCD and to 
remove image curvature and keystone that are distortions imparted onto the spectral data from 
the spectrometer.  MCR was then used to determine the pure spectral emission components and 
the corresponding concentration images of the preprocessed spectral images.  This imager was 
used to 1) attain the spectral components of an untreated RO membrane and 2) determine the 
spatial distribution of ceragenin intensity and median intensity for the treated RO membranes. 
The other imager is a 3D confocal hyperspectral fluorescent microscope that was developed to 
enhance our research into a variety of biological systems at a microscopic level (e.g., host-
pathogen interactions in innate immune cells, investigating photosynthesis in cyanobacteria, and 
understanding plant tissue systems for biofuel applications) [Sinclair et al., 2006].  To image the 
ceragenins, small amounts of each ceragenin formulation were dissolved in water.  Once 
dissolved, each aqueous solution was placed onto an individual quartz coverslip and allowed to 
 16
dry.  Each dried formulation was then imaged using a 488 nm excitation wavelength with an 
infinity-corrected 10x apochromatic objective to collect a 100 m field of view (FOV) image.  
Only one confocal slice was collected for each X-Y location.  At this FOV, each pixel was 0.5 by 
0.5 m in size and each image consisted of 204 by 208 pixels for a total of 42432 pixels or 
spectra.  Each emission spectrum consisted of 512 wavelengths with a spectral resolution of 1-3 
m.  Prior to the MCR analysis of these hyperspectral images, these images were preprocessed to 
improve the quality of the spectral data.  The preprocessing steps included: 1) removing cosmic 
spikes that may have been inadvertently collected onto the EMCCD 2) subtracting the dark 
image from the data and 3) removing an offset component that is added to the spectral data 
during the image collection step.  After the hyperspectral image data were preprocessed, MCR 
was used to extract the pure emission spectra along with the corresponding concentration 
(intensity) images for each pure spectrum.  These concentration images were then used to create 
RGB images for the various ceragenin formulations to check for homogeneity of the emission 
components.  This imager was used to 1) attain spectral components of CSA-13, CSA-105, and 
CSA-109 and 2) examine CSA-105 in more detail to understand the ceragenins homogeneity. 
2.2.2.2 Results 
To identify the individual spectral components hyperspectral images were collected on 1) an 
untreated RO membrane, and 2) CSA-13, CSA-105, and CSA-109 individually.  The untreated 
membrane was imaged using the hyperspectral scanner, while three different dried ceragenin 
formulations (CSA-13, CSA-105, and CSA-109) were imaged using the 3D confocal 
hyperspectral microscope.  MCR analyses extracted the pure emission spectra from the 
hyperspectral images for the RO membrane and the three different ceragenin formulations 
(Figure 6).  Due to spectral artifacts, each real spectral component had a spectral shift component 
associated with it.  On the hyperspectral scanner, these spectral shift components are related to 
the imperfect correction of the keystone and curvature artifacts associated with the imager.  On 
the 3D confocal microscope, these spectral shift components are thought to be due to changes in 
the refractive indices of these dried samples.  Due to these spectral shift components, the peak 
locations listed below are approximate and could change depending on how MCR models the 
shift and real components of the images (the MCR model is a linear combination of the real and 
shift components). 
The RO membrane has two distinct autofluorescent components with peaks at approximately 522 
and 595 nm (Figure 6A).  The second autofluorescent component (Autofluorescence #2) is weak 
and cannot be detected when much stronger fluorophores are present.  The CSA-13 (ceragenin 
without an amide connector or a fluorophore) has an autofluorescence component with a peak at 
approximately 554 nm; however, it is extremely weak (Figure 6B).  Unexpectedly, CSA-109 
(ceragenin with an amide connector but no fluorophore) had a distinct autofluorescent 
component with a peak at approximately 600 nm (Figure 6C).  This result might suggest that the 
amide connector has its own distinct autofluorescent component.  Finally, the spectral 
components detected when imaging CSA-105 (ceragenin with an amide connector and NBD 
fluorophore) include the component detected when imaging CSA-109 and the component 
expected from the NBD (Figure 6D).  In summary, we determined that while the ceragenin has 
its own autofluorescence, it is relatively weak compared to that of the untreated RO membrane, 
the amide connector and the NBD fluorophore.  In addition, the CSA-105 has two distinct 
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Figure 6.  Pure spectral components of (A) an untreated RO membrane, (B) CSA-1
(C) CSA-109, and (D) CSA-105.  Current results suggest that membrane 
Autofluorescence #2 (A) and autofluorescence in CSA-13 (B) are weak and should 
be hard to detect in the presence of any other stronger emitting fluorophores. 
3, 
components, one from the amide connector and the other from the NBD fluorophore.  
Unfortuntately, there appears to be overlap between these two components and that detected in 
the autofluorescence of the untreated RO membrane. 
Although a comparison between the intensities of the various formulations and the RO 
membrane are made above, there was no attempt to keep the concentrations of the formulations 
constant.  Future experiments should consist of imaging these ceragenin solutions at the same 
concentration to get a better understanding of the relative emission intensities of the various 
formulations.  With a complete understanding of the relative emission intensities and the noise 
characteristics of our imagers, an evaluation of the sensitivity of our measurement can be 
determined. 
Three membranes coated with ceragenin (CSA-105 – ceragenin with an amide connector and 
NBD fluorophore) as described Section 2.1.2 and 2.2.1 were imaged using the hyperspectral 
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scanner [Sinclair et al., 2004].    The three pure spectral components obtained from MCR for the 
ceragenin coated membranes (Figure 7) are:  1) the stronger of the two components from the 
autofluorescence of the membrane shown in Figure 6A, 2) the NBD fluorophore as seen in 
Figure 6D, and the amide connector component as seen in Figure 6C and D. 
Figure 8 presents both concentration images and the corresponding intensities for both the NBD 
fluorophore and the amide connector spectral components from Figure 7.  The median intensity 
of both the NBD fluorophore and the amide connector autofluorescence increases as a function 
of the reaction time of the RO membrane with the ceragenin solution.  It also appears that the 24 
hour reaction time provides the best spatial ceragenin coverage across the membrane.  Although, 
the images look more uniform at 24 hours, there still appears to be very bright anomalies present.   
The 3D confocal hyperspectral microscope was used to investigate these anomalies.  There 
appears to be large particulates of excess NBD in the ceragenin that did not attach to the 
ceragenins core via the amide connector (Figure 9). 
The initial plan was to use the NBD fluorophore to visualize the ceragenin coating on the 
membrane.  However since this amide connector is necessary to connect the ceragenin to the 
membrane and it has fluorescence, we may not need an explicit fluorophore to be attached to the 
ceragenin to characterize the coating quality.  We will use hyperspectral imaging in future 
studies to develop a membrane coating protocol that provides the best coating coverage and 
uniformity for our RO membranes. 
Figure 7.  Pure spectral components of ceragenin (CSA-105) treated RO m
The red spectrum is the native auto-fluorescence present in the RO membrane, th
green spectrum is the NBD fluorophore attached to the ceragenin and the blue 
spectrum is due to the amide connector. 
embrane.  
e 
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Figure 8.  Concentration images of the NBD fluorophore and the amide connector 
autofluorescence components found in the CSA-105 treated membranes.  These 
concentration images have been altered to improve the contrast (intensities at or 
above 6000 for the NBD component or 2000 for the amide connector component are 
represented with the same color).  Histograms for each concentration map are shown 
beneath each image, where a bar represents the number of pixels (y-axis) at a specific 
concentration or intensity (x-axis).   The median concentration of both components 
increases as function of reaction time.  It also, appears that the coating becomes more 
uniform after 24 hours of reaction time.  Dimensions of these images acquired on the 
hyperspectral scanner are 6 x 10 mm in size with the pixel size being 30 m square. 
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Figure 9.  Pure images of ceragenin (CSA-105) taken with confocal 
imager.  The NBD fluorophore is shown in green and the amide connector 
autofluorescence component is shown in blue (see Figure 6 for spectra).  
Images have a 100-m field of view with a pixel size of 0.5 m square.  
Just like the ceragenin (CSA-105) coated membranes, these images have 
what appears to be NBD particulate that is not bound to the amide 
connector (as indicated by the white arrows).  The image outlined in red 
shows the highest degree of uniformity. 
 
 21
3 BIOCIDAL ACTIVITY OF CERAGENINS 
This section presents minimum inhibition concentration and minimum bactericidal concentration 
of Pseudomonas fluorescens with CSA-13.  Testing of the biocidal activity of CSA-13 on a 
Pseudomonas fluorescens biofilm is presented.  Finally, testing of the biocidal activity of CSA-
105 attached to a water-treatment membrane is also discussed. 
3.1 MICs and MBCs 
Minimum inhibition concentration (MICs) and minimum bactericidal concentrations (MBCs) are 
typically used to assess antibacterial activity on planktonic bacteria.  MICs measure at what 
concentration a compound, in this case the ceragenin, inhibits the growth of a bacteria strain.  
MBCs measure at what concentration a compound kills the bacteria.  MICs and MBCs have been 
reported for CSA-13 against Pseudomonas aeruginosa [Chin et al., 2008], CSA-8 and CSA-13 
for Staphylococcus aureus [Chin et al., 2007], and CSA-13 compared to other antibiotics against 
many clinical isolates of drug-resistant S. aureus [Lai et al., In Press].  Pseudomonas fluorescens 
is the bacteria being used to evaluate the ceragenins on RO membranes, therefore, MICs and 
MBCs for CSA-13 on P. fluorescens was deemed important. 
3.1.1 Methods 
Kill kinetics were performed with CSA-13 for P. fluorescens [ATCC 700830] using the protocol 
in NCCLS [1997].  The assay was performed in Mueller-Hinton broth (MHB) at time points 2, 4 
and 6 hours on a 106 CFU/mL inoculate of P. fluorescens.  Assays were performed in triplicate.  
A 100 µL sample was removed at each time point, serially diluted, plated on Mueller-Hinton 
agar (MHA), and incubated at 37o C for 24 hours.  Triplicate plates were generated for each 
sample.  Plates were counted and kill kinetics were determined.  MIC was determined by 
comparing the data collected after 2 hours of incubation to the initial inoculum concentrations.  If 
the concentration decreased, then that ceragenin concentration is considered to be at or above the 
MIC.  MBC was determined by the concentration at which 100% of the initial inoculum was 
killed.  The CSA-13 concentrations examined were 1, 2, 3, 4 and 5 μg/mL. 
3.1.2 Results 
Results indicate a MIC of approximately 1 μg/L of CSA-13 for P. fluorescens (Figure 10).  This 
can be seen by the greater than four log reduction in P. fluorescens concentrations after 2 hours 
of incubation.  Given the large decrease, it is possible that the MIC could be even lower than 1 
μg/L of CSA-13.  The MBC was approximately 2 μg/L (Figure 10) as seen by the 100% kill rate 
with CSA-13 concentrations of 2 μg/L for incubation times of 4 hours and greater. 
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Percent Killed: 
100% 100% 100% 
3.2 Impact of ceragenins on established biofilms 
The purpose of this experiment was to determine if ceragenins were effective in killing bacteria 
in established biofilms.  To do this, biofilms were grown in a drip flow reactor.  After biofilm 
development, a solution containing ceragenins was pipetted on to the biofilm.  The biofilm was 
then stained with a live/dead stain and examined microscopically to determine whether it 
differed from a biofilm that had not been treated with ceragenins. 
3.2.1 Methods 
Biofilms were grown in a drip flow reactor using glass microscope slides.  Each of four 
chambers of the reactor were filled with 1 ml of 2.3 × 109 CFU/ml of Pseudomonas fluorescens 
[ATCC 700830] inoculum and 10 ml of pure Trypticase Soy Broth (TSB).  The P. fluorescens 
incubated in the reactor in the flat position for 24 hours.  After this incubation period, the reactor 
was tilted so the slope was approximately 10˚ and dripping of nutrient and neutralizing solutions 
commenced at a flow rate of 1 ml/min.  Solutions of 1:100 TSB were used.  Flow through the 
chambers continued for 6 days. 
After growing the biofilms, two slides had 10 μl of 139 μg/ml of the CSA-13 dropped in the 
middle of the slide.  The other two samples were untreated.  The slides were allowed to sit for 10 
minutes prior to staining.  The biofilms were stained with LIVE/DEAD® BacLight™ bacterial 
viability kit (Invitrogen) using 30 μM propidium iodine and 5 μM SYTO® 9.  The stain remained 
on the biofilm for 15 minutes in the dark before it was rinsed three times with 0.1 M NaHCO3.  
Figure 10.  Results showing a MBC of approximately 2 µg/mL of CSA-13 with 
Pseudomonas fluorescens.  Percent killed values are shown in red. 
98.5% 
99.9% 
99.4% 
99.8% 
100% 100% 100% 100% 00% 100% 100% 1100% 
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Propidium iodine, which fluoresces red in the visible spectral region, only penetrates cell 
membranes that are compromised and is thus indicative of dead or compromised cells.  SYTO® 
9, which fluoresces green in the visible spectral region, indicates live cells or cells with 
uncompromised cell membranes.  
The 3D hyperspectral confocal microscope was used to measure the effect of applying ceragenin 
to the surface of the biofilm.  Images were acquired with a 20x objective (50 m FOV) using 488 
nm laser excitation.  Nine confocal optical sections were acquired penetrating to a total depth of 
8 m into each biofilm sample imaged.  Images were acquired on both the samples with and 
without ceragenin applied to the biofilm.  Once these images were acquired, MCR was used to 
generate the pure component spectra of SYTO® 9 and propidium iodide, as well as the 
corresponding concentration (intensity) images for each component.  Also, the concentration 
images of SYTO® 9 were divided by the concentration images of propidium iodide to provide 
images of the live/dead ratios of the bacteria in the images. 
3.2.2 Results 
Data collected from the hyperspectral imager indicate that there are more dead or compromised 
cells in the biofilm that was treated with the ceragenins.  Figure 11 shows two representative 
optical sections (one with no ceragenins added and one with ceragenins added).  There are two 
No Ceragenins 
Added 
Ceragenins 
Added 
Live:Dead 
Ratio 
Live (Green) 
Dead (Red) 
More Live Cells 
More 
Dead 
Cells 
A B 
Propidium 
iodone peak 
(dead cells) 
SYTO® 9 
peak (live 
cells) 
Figure 11.  Hyperspectral data showing more dead cells in ceragenin-treated 
biofilms.  Images (A) showing LIVE/DEAD® staining with more cells stained with 
propidium iodine (red) in the ceragenin-treated biofilm and more compromised cells 
when looking at the Live:Dead ratio.  Plot of mean intensity of all the voxels in the 
entire image (B) showing greater SYTO® 9 intensity for the untreated sample (blue 
line) indicating more live cells and greater propidium iodine intensity for ceragenin-
treated biofilm (red line), indicating more compromised cells. 
 24
sets of images in Figure 11.  The first set of images is RGB images in which SYTO® 9 is 
represented in green and propidium iodide is represented in red.  The ceragenins–treated sample 
appears more red and the untreated sample appears more green indicating that the bacteria appear 
to more compromised when treated with ceragenin.  This is further confirmed when looking at 
the second set of images.  These live/dead (SYTO® 9/propidium iodide) ratio images show that 
there are more dead bacteria in the sample when ceragenins had been added.   Another way to 
use the spectral image data is to look at the mean spectrum obtained from the approximately 
40,000 spectra in each image and directly compare the peak intensities of SYTO® 9 with the 
peak intensities of propidium iodide.  Figure 11 shows the peak intensity of propidium iodide 
(more dead bacteria) is greater than the peak intensity of SYTO® 9 for the image where 
ceragenins were added to the biofilm.  The opposite is true when there was no ceragenin added to 
the biofilm. 
3.3 Testing of membranes with attached ceragenins 
After successfully attaching the ceragenins to the RO membranes (see Section 2.2.2).  These 
membranes were exposed to bacteria for the purposes of imaging on the confocal hyperspectral 
microscope and enumeration (via plate counts) to determine the biocidal activity of the attached 
ceragenin.  Unfortunately, the proper staining protocol was not followed when preparing the 
samples for the hyperspectral imager.  Therefore, only the results from the enumeration  
experiment are reported here, however methods outlining the sample preparation for both 
imaging and enumeration have documented in the methods section. 
3.3.1 Methods 
Two sample preparation protocols were used for testing the biocidal activity of the ceragenins on 
RO membranes.  For imaging, six membranes were put into centrifuge vials with a solution of 
bacteria.  For enumeration experiment, only the side of the membrane that was treated with 
ceragenins could be exposed to bacteria, so a second protocol was developed.  In both tests, six 
membranes were analyzed:  three with ceragenins attached and three untreated RO membranes.  
The ceragenin-coated membranes had reaction times of 1, 2, and 24 hours as described in section 
2.2.2. 
3.3.1.1 Imaging Test 
Prior to the start of the tests, the six membranes were disinfected by soaking them in ethanol 
overnight.  20 ml of 6.2 × 105 CFU/ml of Pseudomonas fluorescens [ATCC 700830] inoculum 
was added to a sterile 50 ml conical centrifuge vials (Falcon 21088-939).  Each membrane was 
removed from the ethanol and rinsed with copius amounts of sterile deionized water and placed 
into a labeled vial.  The vials were allowed to incubate on a shaker table set at 50 rpm for 24 
hours.  The solutions were then sampled from each vial for plating.  The remaining liquid was 
poured out of the tube and the membrane removed.  The membrane was rinsed three times with 
sterile deinoize water and then stained with the LIVE/DEAD® BacLightTM as described in 
Section 3.2.1.  Unfortunately, the stain was never rinsed off prior to imaging, which adversely 
affected the imaging results.  
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3.3.1.2 Enumeration Test 
Glass vacuum filter holders [Advantec 13 mm Glass Microanalysis Holders] as shown in Figure 
12 were used for the plate counting tests.  The filter holders were autoclaved at 121 ˚C and 15 psi 
for 15 minutes prior to the start of the experiment.  To maintain sterility, both the top and bottom 
were covered with aluminum foil prior to autoclaving.  A small amount of silicon grease was 
also applied to one side of the filter holder.  The grease was needed to prevent leaking during the 
test.  Likewise, the RO membranes were sterilized by soaking in ethanol overnight.  Each 
membrane was placed in the glass filter holder and this apparatus placed on a shaker table.  5 ml 
of 6.2 × 105 CFU/ml of Pseudomonas fluorescens inoculum was added to the top of the filter 
holders.  The systems were allowed to shake at 50 RPM while at room temperature for 
approximately 24 hours.   
Following the 24 hours, the membranes were then ready for sampling.  Each membrane was 
removed from the bottom part of the filter holder with sterile tweezers and rinsed 3 times with 
the sterile DI water.  The membrane was placed into a 15 ml conical vial (VWR 20171-008) 
filled with 10 ml of sterile DI water.  The vial was vortexed, sonicate for 15 minutes, and then 
vortex again. An 1 ml aliquot of this solution was then plated for enumeration. 
Samples for plating were serially diluted and enumerated using Trypticase Soy Agar (TSA).  
Triphenyl Tetrazolium Chloride (BD Biosciences) was added to the TSA to facilitate 
enumeration.  The volume concentration of Triphenyl Tetrazolium Chloride was 0.01%.  
Quadruplicate plates were prepared for each dilution.  Plates were incubated at 30 °C for 48 
hours prior to enumerating.  Results are reported as the mean and standard deviation of the four 
plates. 
3.3.2 Results 
Results of the enumeration test indicate that the amount of bacteria on ceragenin-coated 
membrane that reacted with the ceragenin solution for 1 hour is not significantly different than 
Figure 12.  Photograph of glass filter holders used to test biocidal activity on 
ceragenin-treated RO membranes. 
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the controls (Table 1 and Figure 13).  However, the cell density on the membrane that reacted 
with the ceragenin solution for 24 hours was approximately 1 order of magnitude less than the 
control (Table 1 and Figure 13).  These preliminary results are not as strong as testing conducted 
on endotracheal tubes where counts remained less than 50 CFU’s after 14 days of soaking in 
bacterial solution (Paul Savage, personal communication).  However, for a first try, these results 
are still promising. 
 
Table 1.  Results of Enumeration Tests 
Sample Description 
Average (Standard Deviation) 
Bacteria Density on Membrane 
(CFU/cm2) 
Average (Standard Deviation) 
Final Bacteria Concentration in 
Solution (CFU/ml) 
Control 1 Membrane Contaminated 7.2 × 107 (5.7 × 106) 
Control 2 2.1 × 107 (1.9 × 106) 7.5 × 107 (7.4 × 106) 
Control 3 7.6 × 106 (1.1 × 106) 4.9 × 108 (7.0 × 107) 
1-hr ceragenin coating time 1.1 × 107 (1.1 × 105) 8.3 × 108 (6.1 × 107) 
2 hr ceragenin coating time Membrane Contaminated 7.3 × 108 (1.1 × 108) 
24-hr ceragenin coating time 9.6 × 105 (6.6 × 104) 2.6 × 108 (4.8 × 107) 
 
Figure 13:  Results of enumeration testing showing that membrane soaked in 
ceragenin solution for 24 hours yielded cell densities approximately an order of 
magnitude lower than the controls and the membrane that soaked in the ceragenin 
solution for 1 hour. 
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4 SUMMARY AND FUTURE WORK 
The work presented in this report provides evidence that  
 The ceragenins CSA-105 can be attached to RO membranes 
 The ceragenin CSA-13 is effective at killing planktonic Pseudomonas fluorescens with 
measured MIC’s of approximately 1 μg/L and MBC of 2 1 μg/L. 
 The ceragenin CSA-13 is effective at killing Pseudomonas fluorescens in biofilms 
In addition, there is promising evidence that less viable P. fluorescens will stick to a RO 
membrane with linked ceragenins than to an untreated membrane as shown in Figure 13. 
This study allowed for a careful analysis of our techniques for imaging ceragenins.  It was 
discovered that there were three fluorescent components present when imaging the ceragenin 
membranes:  a component that is related to the autofluorescence from membrane, the NBD 
fluorophore, and a component somehow related to the amide connector that is attached to the 
ceragenin.  NBD was also an effective fluorescent tag.  However, the spectrum of the NBD had 
much greater overlap with that of the autofluorescence of the untreated RO membrane.  Future 
work will include better assessing the relative intensities of the different fluorescent components 
to determine whether the fluorescence signal emanating from the amide connector is sufficient 
for characterizing the ceragenin coating or whether an explicit fluorophore is needed.  In 
addition, artifacts due to spectral shift components in the hyperspectral imagers need to be better 
understood in order to determine more accurate peak locations and spectral components. 
Images of RO membranes treated with CSA-105 indicated inhomogeneous attachment of the 
ceragenin to the membrane.  Additional work is needed to more uniformly attach the ceragenin.  
This will be done by developing a two-step procedure for attachment method 1.  The first step 
will be to treat the membrane surface with an epoxy-alkene such as 3,4-epoxy-1-butene in order 
to allow the amines on the surface to react with the epoxy groups.  After washing off the excess 
epoxy-alkene, the surface will have covalently bound alkene groups which will serve as the 
points of attachment for the poly(acrylate)-type oligomers which will be formed in the second 
step as described in section 2.2.1 above.  This method will also eliminate the ambiguity in the 
attachment mechanism.  In addition to this change in the procedure for method 1, a better 
apparatus for bounding the reaction solution on the membrane surface has been developed.  
Instead of using an o-ring, a polycarbonate frame will be compressed against the membrane 
surface to hold the solution in place.  It will be deep enough to allow for an even depth of 
reaction solution over the entire surface and it will be covered to prevent solvent evaporation 
during the attachment procedure.   
In summary, this scoping study has provided promising evidence that linking ceragenins to 
water-treatment membranes could create biofouling resistant water-treatment membranes.  
However, future work is needed in order to better design the membrane and completely test the 
biocidal effectiveness of the ceragenin in this context. 
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